We are international
Donate
• about myeloma TEXT SIZE   
   back

Fall 2005 Volume 6, Issue 6:
Insights into New Myeloma Tx: Revlimid Study Tops List of Investigations that may Benefit Patients
By Ruben Niesvizky, MD
Recently, the Myeloma Program at New York-Presbyterian Hospital/Weill Cornell Medical Center has generated a considerable amount of excitement by launching a study evaluating a combination regimen, known as BiRD, that includes the antibiotic Biaxin&r
12.08.05

Be the first to comment

 related articles